[Combined polychemotherapy of patients with chronic hepatitis C].
Nikitin
I G
IG
Storozhakov
G I
GI
Kuznetsov
S L
SL
Strochenovskiĭ
A B
AB
D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000276:immunology; D000998:Antiviral Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D019258:Saquinavir / Q000627:therapeutic use*
D000914:Antibodies, Viral; D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D016898:Interferon-alpha; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D019258:Saquinavir
Kombinirovannaia polikhimioterapiia patsientov khronicheskim HCV-gepatitom.